secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001638833-23-000080
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q2 revenue $667.6M (+8.5% YoY), EBITDA beat; FY guidance raised
--------------------------------------------------------------------------------

- Revenue $667.6M (+8.5% YoY); same-facility revenue +8.3% (~10% adj. for $8M cyber headwind).
- Net income $18.9M vs ($18.4M) loss; Adjusted EBITDA $100.2M, +16.4% YoY; margin 15.0%.
- FY 2023 Adjusted EBITDA guidance raised to >$435M; revenue reaffirmed >$2.75B; free cash flow >$140M.
- Combined surgical case volume +5%; non-consolidated minority revenue +30%.
- Deployed ~$60M capital in Q2; new partnership with Methodist Health System in Dallas, TX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/0001638833-23-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/sgry-20230801.htm
  HTML page:      https://secwatch.observer/filing/0001638833-23-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer